CAR-T-терапия при раке: онколог оценил шансы Лерчек на лечение, эффективность метода
CAR-T-терапия при раке: онколог оценил шансы Лерчек на лечение, эффективность метода ТВ Mail
Онкология
Иммунотерапия и CAR-T
185 материалов по теме, собраны автоматически из проверенных источников
Онкология
Smarter CAR-T cells could beat a deadly pediatric brain cancer
Scientists at UC San Francisco have engineered CAR-T cells that stay dormant until they reach the brain, where they switch on and destroy tumor cells. In mice, these CAR-T cells were able to clear diffuse midline glioma (DMG), a lethal form of childhood brain cancer that integrates into healthy tissue. The cells also…
🎗️
Онкология
Vir Biotechnology Appoints Cancer Immunotherapy Expert Suzanne Topalian to Board
Vir Biotechnology Appoints Cancer Immunotherapy Expert Suzanne Topalian to Board citybiz
Онкология
Study Warns on Immunotherapy De-Escalation in Advanced Cancers
Study Warns on Immunotherapy De-Escalation in Advanced Cancers MedPage Today
Онкология
Preclinical research shows macrophages can be programmed to fight solid cancer tumors
One person dies every 50 seconds in the U.S. from cancer, and an estimated 39% of people in the country will develop cancer during their lifetime. Survival rates have improved in recent decades from innovations and combinations of treatments, including surgery, chemotherapy, radiation, immunotherapy and biotechnology…
🎗️
Онкология
Novel Cancer Immunotherapy Drug Generates Promising Clinical Trial Results
Novel Cancer Immunotherapy Drug Generates Promising Clinical Trial Results Cancer Health
Онкология
РНЦРР проведет КИ CAR-T-препарата для лечения рака яичника
РНЦРР проведет КИ CAR-T-препарата для лечения рака яичника Vademec.ru
Онкология
Immunotherapy combination extends survival in advanced endometrial cancer
An immunotherapy-based regimen combining durvalumab and the PARP inhibitor olaparib demonstrated encouraging long-term survival outcomes for patients with advanced or recurrent endometrial cancer, according to new trial results presented by researchers from The University of Texas MD Anderson Cancer Center.
Онкология
Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences Announces Completion of Treatment of Fifth Cohort in its Ovarian Cancer CAR-T Clinical Trial Morningstar
Онкология
QL1706 at ESMO 2026: Dual PD-1/CTLA-4 Immunotherapy Improves Overall Survival in Advanced Cervical Cancer
QL1706 at ESMO 2026: Dual PD-1/CTLA-4 Immunotherapy Improves Overall Survival in Advanced Cervical Cancer Oncodaily
Онкология
ESMO 2026: Immunotherapy combination extends survival in advanced endometrial cancer
ESMO 2026: Immunotherapy combination extends survival in advanced endometrial cancer UT MD Anderson
Онкология
ESMO 2026: Immunotherapy Combination Extends Survival in Advanced Endometrial Cancer | Newswise
ESMO 2026: Immunotherapy Combination Extends Survival in Advanced Endometrial Cancer | Newswise Newswise
Онкология
A precision T-cell therapy stalls treatment-resistant cancers in clinical trial
Early results of the first clinical trial to evaluate the drug invikafusp alfa (invika) in humans indicate that the treatment may be capable of managing cancers that have rebuffed most other interventions, including standard immunotherapy.
Онкология
Novel cancer immunotherapy drug generates promising clinical trial results
Novel cancer immunotherapy drug generates promising clinical trial results Mass General Brigham
Онкология
Novel cancer immunotherapy drug generates promising clinical trial results
Novel cancer immunotherapy drug generates promising clinical trial results Mass General Brigham